Product Information
LIDOCAINE 5% OINTMENT is a generic product labeled by Quagen Pharmaceuticals LLC, priced at $0.1621 per GM under NDC 70752011303. Its NADAC has been published 211 times since Sep 21, 2022.
FDA first approved this application on Apr 20, 2021. Its Orange Book therapeutic-equivalence code is AT.
Strength
50 mg/g
Manufacturer
Quagen Pharmaceuticals LLCNDC
70752011303
Classification
Generic
Dosage Form
OINTMENT
Route
TOPICAL
Effective Date
9/23/2026
Active Ingredients
LIDOCAINEApproval Type
Generic (ANDA)
FDA Application
ANDA212695FDA Approved
4/20/2021
TE Code
AT
On Market Since
4/20/2021
Pharmacological Classes
Price Statistics
The NADAC for LIDOCAINE 5% OINTMENT has been published 211 times since Sep 21, 2022, and over the history we have for it it has declined 11.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1621 per GM |
|---|---|
| All-time high | $0.1979 (Mar 13, 2024) |
| All-time low | $0.1320 (Apr 17, 2024) |
| 52-week high | $0.1683 |
| 52-week low | $0.1574 |
| Median price | $0.1683 |
| Average price | $0.1685 |
| Largest weekly change | -29.2% (Apr 17, 2024) |
| Weeks tracked | 211 |
| Tracking since | Sep 21, 2022 |
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 11% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Quagen Pharmaceuticals LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Lidocaine market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Amide Local Anesthetic class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of LIDOCAINE 5% OINTMENT?
The current National Average Drug Acquisition Cost (NADAC) for LIDOCAINE 5% OINTMENT, manufactured by Quagen Pharmaceuticals LLC, is $0.1621 per GM (NDC 70752011303), effective Sep 30, 2026.
How has the price of LIDOCAINE 5% OINTMENT changed over time?
Over the history we have for it, the NADAC for LIDOCAINE 5% OINTMENT has declined 11.8%. It has been tracked across 211 weekly CMS publications since Sep 21, 2022.
What are the highest and lowest recorded NADAC prices for LIDOCAINE 5% OINTMENT?
Since Sep 21, 2022, the NADAC for LIDOCAINE 5% OINTMENT has ranged from a low of $0.1320 (Apr 17, 2024) to a high of $0.1979 (Mar 13, 2024), with a median of $0.1683 per GM.
Are there cheaper alternatives to LIDOCAINE 5% OINTMENT?
Yes. 5 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, LIDOCAINE 5% OINTMENT, is $0.1442 per GM — about 11% below LIDOCAINE 5% OINTMENT.
Who manufactures LIDOCAINE 5% OINTMENT?
LIDOCAINE 5% OINTMENT (NDC 70752011303) is labeled by Quagen Pharmaceuticals LLC, and CMS classifies it as a generic product.